Article Dans Une Revue Frontiers in Immunology Année : 2025

Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19

Olivier Desebbe
  • Fonction : Auteur
Bertrand Delannoy
  • Fonction : Auteur
Sophie Demeret
Mathieu Schoeffler
  • Fonction : Auteur
Paul Simon Pugliesi
  • Fonction : Auteur
Sophie Debord
  • Fonction : Auteur
Jean Laurent Casanova
  • Fonction : Auteur
Rémi Pescarmona
  • Fonction : Auteur

Résumé

Background: Immunological disturbances (anti-type I IFN auto-antibody production, cytokine storm, lymphopenia, T-cell hyperactivation and exhaustion) are responsible for disease exacerbation during severe COVID-19 infections. Methods: In this study, we set up a prospective, randomised clinical trial (ClinicalTrials.gov ID: NCT04751643) and performed therapeutic plasma exchange (TPE) in severe COVID-19 patients in order to decrease excess cytokines and auto-antibodies and to assess whether adding TPE to the standard treatment (ST, including corticosteroids plus high-flow rate oxygen) could help restore immune parameters and limit the progression of acute respiratory distress syndrome (ARDS). Results: As expected, performing TPE decreased the amount of anti-type I IFN auto-antibodies and improved the elimination or limited the production of certain inflammatory mediators (IL-18, IL-7, CCL2, CCL3, etc.) circulating in the blood of COVID-19 patients, compared to ST controls. Interestingly, while TPE did not influence changes in ARDS parameters throughout the protocol, it proved more effective than ST in reversing lymphopenia, preventing T-cell hyperactivation and reducing T-cell exhaustion, notably in a fraction of TPE patients who had an early favourable respiratory outcome. TPE also restored appropriate numbers of CD4+ and CD8+ T–cell memory populations and increased the number of circulating virus-specific T cells in these patients. Conclusion: Our results therefore indicate that the addition of TPE sessions to the standard treatment accelerates immune cell recovery and contributes to the development of appropriate antiviral T-cell responses in some patients with severe COVID-19 disease.

Fichier principal
Vignette du fichier
fimmu-15-1492672.pdf (3.81 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04996087 , version 1 (18-03-2025)

Licence

Identifiants

Citer

Aurelie Guironnet-Paquet, Hind Hamzeh-Cognasse, Frederic Berard, Fabrice Cognasse, Jean Christophe Richard, et al.. Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19. Frontiers in Immunology, 2025, 15, pp.1492672. ⟨10.3389/fimmu.2024.1492672⟩. ⟨hal-04996087⟩
455 Consultations
73 Téléchargements

Altmetric

Partager

  • More